JPMorgan lowered CrowdStrike's price target to $472 but maintained an overweight rating, calling the recent selloff "overdone". Analyst Brian Essex expects strong Q4 performance with a durable sales pipeline. The firm suggests the stock drop is a valuation recalibration rather than a sign of weakening fundamentals following Anthropic's product launch.